Alterity Therapeutics (ATHE) Return on Sales (2016 - 2020)

Alterity Therapeutics' Return on Sales history runs 5 years deep, the most recent figure standing at 0.0% for Q4 2020.

• In Q4 2020, Return on Sales rose 2.0% year-over-year to 0.0%; the TTM figure through Dec 2020 stood at 0.0% (up 1.0% YoY), while the FY2024 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Sales was 0.0% for Q4 2020 at Alterity Therapeutics, up from 0.02% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.0% in Q4 2020 to a low of 0.03% in Q4 2017.
• Historically, Return on Sales has averaged 0.01% across 5 years, with a median of 0.01% in 2016.
• The sharpest annual moves came in 2017 and 2018: Return on Sales fell 2 bps in 2017, then gained 2 bps in 2018.
• A 5-year view of Return on Sales shows it stood at 0.01% in 2016, then sank by 224 bps to 0.03% in 2017, then soared by 76 bps to 0.01% in 2018, then plunged by 195 bps to 0.02% in 2019, then jumped by 100 bps to 0.0% in 2020.
• The last three Return on Sales figures came in at 0.0% (Q4 2020), 0.02% (Q4 2019), and 0.01% (Q4 2018), per Business Quant data.